ESR1 and breast cancer: Consistent with the previous research results, grade 3, T2, no chemotherapy, fewer examined lymph nodes (4–13), more positive axillary lymph nodes, ER-negative, and PR-negative were independent risk factors for prognosis of T1–2 breast cancer with 1–3 positive axillary lymph nodes (11–24, 37).